Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Insulin resistance and chronic kidney disease progression, cardiovascular events, and death: findings from the chronic renal insufficiency cohort study.

Schrauben SJ, Jepson C, Hsu JY, Wilson FP, Zhang X, Lash JP, Robinson BM, Townsend RR, Chen J, Fogelfeld L, Kao P, Landis JR, Rader DJ, Hamm LL, Anderson AH, Feldman HI.

BMC Nephrol. 2019 Feb 20;20(1):60. doi: 10.1186/s12882-019-1220-6.

2.

Incident Type 2 Diabetes Among Individuals With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.

Jepson C, Hsu JY, Fischer MJ, Kusek JW, Lash JP, Ricardo AC, Schelling JR, Feldman HI; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators.

Am J Kidney Dis. 2019 Jan;73(1):72-81. doi: 10.1053/j.ajkd.2018.06.017. Epub 2018 Sep 1.

PMID:
30177484
3.

Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.

Koye DN, Magliano DJ, Reid CM, Jepson C, Feldman HI, Herman WH, Shaw JE.

Am J Kidney Dis. 2018 Nov;72(5):653-661. doi: 10.1053/j.ajkd.2018.02.364. Epub 2018 May 18.

PMID:
29784612
4.

Statistical Methods for Modeling Time-Updated Exposures in Cohort Studies of Chronic Kidney Disease.

Xie D, Yang W, Jepson C, Roy J, Hsu JY, Shou H, Anderson AH, Landis JR, Feldman HI; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators.

Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1892-1899. doi: 10.2215/CJN.00650117. Epub 2017 Aug 17. Review.

5.

Analytic Considerations for Repeated Measures of eGFR in Cohort Studies of CKD.

Shou H, Hsu JY, Xie D, Yang W, Roy J, Anderson AH, Landis JR, Feldman HI, Parsa A, Jepson C; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators.

Clin J Am Soc Nephrol. 2017 Jul 27;12(8). pii: CJN.11311116. doi: 10.2215/CJN.11311116. Print 2017 Aug 7. Review.

6.

Statistical Methods for Recurrent Event Analysis in Cohort Studies of CKD.

Yang W, Jepson C, Xie D, Roy JA, Shou H, Hsu JY, Anderson AH, Landis JR, He J, Feldman HI; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators.

Clin J Am Soc Nephrol. 2017 Dec 7;12(12):2066-2073. doi: 10.2215/CJN.12841216. Epub 2017 Jul 17. Review.

7.

Statistical Methods for Cohort Studies of CKD: Survival Analysis in the Setting of Competing Risks.

Hsu JY, Roy JA, Xie D, Yang W, Shou H, Anderson AH, Landis JR, Jepson C, Wolf M, Isakova T, Rahman M, Feldman HI; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators.

Clin J Am Soc Nephrol. 2017 Jul 7;12(7):1181-1189. doi: 10.2215/CJN.10301016. Epub 2017 Feb 27.

8.

Statistical Methods for Cohort Studies of CKD: Prediction Modeling.

Roy J, Shou H, Xie D, Hsu JY, Yang W, Anderson AH, Landis JR, Jepson C, He J, Liu KD, Hsu CY, Feldman HI; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators.

Clin J Am Soc Nephrol. 2017 Jun 7;12(6):1010-1017. doi: 10.2215/CJN.06210616. Epub 2016 Sep 22. Review.

9.

Effects of tailored risk communications for skin cancer prevention and detection: the PennSCAPE randomized trial.

Glanz K, Volpicelli K, Jepson C, Ming ME, Schuchter LM, Armstrong K.

Cancer Epidemiol Biomarkers Prev. 2015 Feb;24(2):415-21. doi: 10.1158/1055-9965.EPI-14-0926. Epub 2014 Nov 28.

10.

Hypericum perforatum hydroxyalkylpyrone synthase involved in sporopollenin biosynthesis--phylogeny, site-directed mutagenesis, and expression in nonanther tissues.

Jepson C, Karppinen K, Daku RM, Sterenberg BT, Suh DY.

FEBS J. 2014 Sep;281(17):3855-68. doi: 10.1111/febs.12920. Epub 2014 Jul 28.

11.

The association between changes in alternative reinforcers and short-term smoking cessation.

Goelz PM, Audrain-McGovern JE, Hitsman B, Leone FT, Veluz-Wilkins A, Jepson C, Wileyto EP, D'Avanzo PA, Rivera JG, Schnoll RA.

Drug Alcohol Depend. 2014 May 1;138:67-74. doi: 10.1016/j.drugalcdep.2014.02.007. Epub 2014 Feb 15.

12.

Evidence from mouse and man for a role of neuregulin 3 in nicotine dependence.

Turner JR, Ray R, Lee B, Everett L, Xiang J, Jepson C, Kaestner KH, Lerman C, Blendy JA.

Mol Psychiatry. 2014 Jul;19(7):801-10. doi: 10.1038/mp.2013.104. Epub 2013 Sep 3.

13.

No untoward effects of smoking cues in anti-smoking public service announcements.

Falcone M, Lerman C, Cappella JN, Sanborn P, Jepson C, Strasser AA.

Drug Alcohol Depend. 2013 Nov 1;133(1):279-82. doi: 10.1016/j.drugalcdep.2013.05.006. Epub 2013 Jun 3.

14.

Epididymal specific, selenium-independent GPX5 protects cells from oxidative stress-induced lipid peroxidation and DNA mutation.

Taylor A, Robson A, Houghton BC, Jepson CA, Ford WC, Frayne J.

Hum Reprod. 2013 Sep;28(9):2332-42. doi: 10.1093/humrep/det237. Epub 2013 May 21.

PMID:
23696541
15.

Society for Vascular Nursing clinical practice guideline (CPG) for carotid artery stenting.

Treat-Jacobson DJ, Rich K, DeVeaux T, Fitzgerald K, Flood A, Gilpin V, Kirk LN, Smith D, Thomson L, Jepson CA; Society for Vascular Nursing Practice and Research Committee.

J Vasc Nurs. 2013 Mar;31(1):32-55. doi: 10.1016/j.jvn.2012.12.003. No abstract available.

PMID:
23481879
16.

Melanoma genetic testing, counseling, and adherence to skin cancer prevention and detection behaviors.

Glanz K, Volpicelli K, Kanetsky PA, Ming ME, Schuchter LM, Jepson C, Domchek SM, Armstrong K.

Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):607-14. doi: 10.1158/1055-9965.EPI-12-1174. Epub 2013 Feb 7.

17.

Physcomitrella PpORS, basal to plant type III polyketide synthases in phylogenetic trees, is a very long chain 2'-oxoalkylresorcinol synthase.

Kim SY, Colpitts CC, Wiedemann G, Jepson C, Rahimi M, Rothwell JR, McInnes AD, Hasebe M, Reski R, Sterenberg BT, Suh DY.

J Biol Chem. 2013 Jan 25;288(4):2767-77. doi: 10.1074/jbc.M112.430686. Epub 2012 Dec 7.

18.

Graphic warning labels in cigarette advertisements: recall and viewing patterns.

Strasser AA, Tang KZ, Romer D, Jepson C, Cappella JN.

Am J Prev Med. 2012 Jul;43(1):41-7. doi: 10.1016/j.amepre.2012.02.026.

19.

Abnormal vascular development in zebrafish models for fukutin and FKRP deficiency.

Wood AJ, Müller JS, Jepson CD, Laval SH, Lochmüller H, Bushby K, Barresi R, Straub V.

Hum Mol Genet. 2011 Dec 15;20(24):4879-90. doi: 10.1093/hmg/ddr426. Epub 2011 Sep 15.

PMID:
21926082
20.

Association of BDNF and COMT genotypes with cognitive processing of anti-smoking PSAs.

Falcone M, Jepson C, Sanborn P, Cappella JN, Lerman C, Strasser AA.

Genes Brain Behav. 2011 Nov;10(8):862-7. doi: 10.1111/j.1601-183X.2011.00726.x. Epub 2011 Oct 6.

21.

PpASCL, a moss ortholog of anther-specific chalcone synthase-like enzymes, is a hydroxyalkylpyrone synthase involved in an evolutionarily conserved sporopollenin biosynthesis pathway.

Colpitts CC, Kim SS, Posehn SE, Jepson C, Kim SY, Wiedemann G, Reski R, Wee AG, Douglas CJ, Suh DY.

New Phytol. 2011 Dec;192(4):855-68. doi: 10.1111/j.1469-8137.2011.03858.x. Epub 2011 Aug 29.

22.

OMG do not say LOL: obese adolescents' perspectives on the content of text messages to enhance weight loss efforts.

Woolford SJ, Barr KL, Derry HA, Jepson CM, Clark SJ, Strecher VJ, Resnicow K.

Obesity (Silver Spring). 2011 Dec;19(12):2382-7. doi: 10.1038/oby.2011.266. Epub 2011 Aug 25.

23.

Association of the nicotine metabolite ratio and CHRNA5/CHRNA3 polymorphisms with smoking rate among treatment-seeking smokers.

Falcone M, Jepson C, Benowitz N, Bergen AW, Pinto A, Wileyto EP, Baldwin D, Tyndale RF, Lerman C, Ray R.

Nicotine Tob Res. 2011 Jun;13(6):498-503. doi: 10.1093/ntr/ntr012. Epub 2011 Mar 8.

24.

Comparison of a bacteriophage-delivered DNA vaccine and a commercially available recombinant protein vaccine against hepatitis B.

Clark JR, Bartley K, Jepson CD, Craik V, March JB.

FEMS Immunol Med Microbiol. 2011 Mar;61(2):197-204. doi: 10.1111/j.1574-695X.2010.00763.x. Epub 2011 Jan 19.

25.

Mouse model predicts effects of smoking and varenicline on event-related potentials in humans.

Rudnick ND, Strasser AA, Phillips JM, Jepson C, Patterson F, Frey JM, Turetsky BI, Lerman C, Siegel SJ.

Nicotine Tob Res. 2010 Jun;12(6):589-97. doi: 10.1093/ntr/ntq049. Epub 2010 Apr 15.

26.

Genetic variation in nicotine metabolism predicts the efficacy of extended-duration transdermal nicotine therapy.

Lerman C, Jepson C, Wileyto EP, Patterson F, Schnoll R, Mroziewicz M, Benowitz N, Tyndale RF.

Clin Pharmacol Ther. 2010 May;87(5):553-7. doi: 10.1038/clpt.2010.3. Epub 2010 Mar 24.

27.

Convergent evidence that choline acetyltransferase gene variation is associated with prospective smoking cessation and nicotine dependence.

Ray R, Mitra N, Baldwin D, Guo M, Patterson F, Heitjan DF, Jepson C, Wileyto EP, Wei J, Payne T, Ma JZ, Li MD, Lerman C.

Neuropsychopharmacology. 2010 May;35(6):1374-82. doi: 10.1038/npp.2010.7. Epub 2010 Feb 10.

28.

Dok-7 promotes slow muscle integrity as well as neuromuscular junction formation in a zebrafish model of congenital myasthenic syndromes.

Müller JS, Jepson CD, Laval SH, Bushby K, Straub V, Lochmüller H.

Hum Mol Genet. 2010 May 1;19(9):1726-40. doi: 10.1093/hmg/ddq049. Epub 2010 Feb 10.

PMID:
20147321
29.

Working memory deficits predict short-term smoking resumption following brief abstinence.

Patterson F, Jepson C, Loughead J, Perkins K, Strasser AA, Siegel S, Frey J, Gur R, Lerman C.

Drug Alcohol Depend. 2010 Jan 1;106(1):61-4. doi: 10.1016/j.drugalcdep.2009.07.020. Epub 2009 Sep 5.

30.

Ovine trophoblast is a primary source of TNFalpha during Chlamydophila abortus infection.

Wheelhouse N, Wattegedera S, Stanton J, Maley S, Watson D, Jepson C, Deane D, Buxton D, Longbottom D, Baszler T, Entrican G.

J Reprod Immunol. 2009 Jun;80(1-2):49-56. doi: 10.1016/j.jri.2008.12.003. Epub 2009 Apr 9.

PMID:
19361867
31.

Conservation and variation of the parapoxvirus GM-CSF-inhibitory factor (GIF) proteins.

Deane D, Ueda N, Wise LM, Wood AR, Percival A, Jepson C, Inglis NF, Fleming SB, Mercer AA, McInnes CJ.

J Gen Virol. 2009 Apr;90(Pt 4):970-7. doi: 10.1099/vir.0.006692-0. Epub 2009 Mar 4.

PMID:
19264672
32.

Experimental evaluation of antitobacco PSAs: effects of message content and format on physiological and behavioral outcomes.

Strasser AA, Cappella JN, Jepson C, Fishbein M, Tang KZ, Han E, Lerman C.

Nicotine Tob Res. 2009 Mar;11(3):293-302. doi: 10.1093/ntr/ntn026. Epub 2009 Feb 26.

33.

Varenicline improves mood and cognition during smoking abstinence.

Patterson F, Jepson C, Strasser AA, Loughead J, Perkins KA, Gur RC, Frey JM, Siegel S, Lerman C.

Biol Psychiatry. 2009 Jan 15;65(2):144-9. doi: 10.1016/j.biopsych.2008.08.028. Epub 2008 Oct 8.

34.

Mispredicting and misremembering: patients with renal failure overestimate improvements in quality of life after a kidney transplant.

Smith D, Loewenstein G, Jepson C, Jankovich A, Feldman H, Ubel P.

Health Psychol. 2008 Sep;27(5):653-8. doi: 10.1037/a0012647.

PMID:
18823192
35.

An immunisation strategy for the protection of cattle against alcelaphine herpesvirus-1-induced malignant catarrhal fever.

Haig DM, Grant D, Deane D, Campbell I, Thomson J, Jepson C, Buxton D, Russell GC.

Vaccine. 2008 Aug 18;26(35):4461-8. doi: 10.1016/j.vaccine.2008.06.056. Epub 2008 Jul 2.

PMID:
18601965
36.

Effects of atomoxetine on subjective and neurocognitive symptoms of nicotine abstinence.

Ray R, Rukstalis M, Jepson C, Strasser A, Patterson F, Lynch K, Lerman C.

J Psychopharmacol. 2009 Mar;23(2):168-76. doi: 10.1177/0269881108089580. Epub 2008 May 30.

PMID:
18515446
37.

Genetic variation in mu-opioid-receptor-interacting proteins and smoking cessation in a nicotine replacement therapy trial.

Ray R, Jepson C, Wileyto EP, Dahl JP, Patterson F, Rukstalis M, Pinto A, Berrettini W, Lerman C.

Nicotine Tob Res. 2007 Nov;9(11):1237-41.

PMID:
17978999
38.

CHRNA4 and tobacco dependence: from gene regulation to treatment outcome.

Hutchison KE, Allen DL, Filbey FM, Jepson C, Lerman C, Benowitz NL, Stitzel J, Bryan A, McGeary J, Haughey HM.

Arch Gen Psychiatry. 2007 Sep;64(9):1078-86.

PMID:
17768273
39.

CREB1 haplotypes and the relative reinforcing value of nicotine.

Ray R, Jepson C, Wileyto P, Patterson F, Strasser AA, Rukstalis M, Perkins K, Blendy J, Lerman C.

Mol Psychiatry. 2007 Jul;12(7):615-7. No abstract available.

PMID:
17592483
40.

CYP2B6 genotype does not alter nicotine metabolism, plasma levels, or abstinence with nicotine replacement therapy.

Lee AM, Jepson C, Shields PG, Benowitz N, Lerman C, Tyndale RF.

Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1312-4. No abstract available.

41.

CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial.

Lee AM, Jepson C, Hoffmann E, Epstein L, Hawk LW, Lerman C, Tyndale RF.

Biol Psychiatry. 2007 Sep 15;62(6):635-41. Epub 2007 Jan 16.

PMID:
17223085
42.

Association of OPRM1 A118G variant with the relative reinforcing value of nicotine.

Ray R, Jepson C, Patterson F, Strasser A, Rukstalis M, Perkins K, Lynch KG, O'Malley S, Berrettini WH, Lerman C.

Psychopharmacology (Berl). 2006 Oct;188(3):355-63. Epub 2006 Sep 8.

PMID:
16960700
43.

Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy.

Malaiyandi V, Lerman C, Benowitz NL, Jepson C, Patterson F, Tyndale RF.

Mol Psychiatry. 2006 Apr;11(4):400-9.

PMID:
16402128
44.

Interaction between variation in the D2 dopamine receptor (DRD2) and the neuronal calcium sensor-1 (FREQ) genes in predicting response to nicotine replacement therapy for tobacco dependence.

Dahl JP, Jepson C, Levenson R, Wileyto EP, Patterson F, Berrettini WH, Lerman C.

Pharmacogenomics J. 2006 May-Jun;6(3):194-9.

PMID:
16402081
46.

Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials.

Lerman C, Jepson C, Wileyto EP, Epstein LH, Rukstalis M, Patterson F, Kaufmann V, Restine S, Hawk L, Niaura R, Berrettini W.

Neuropsychopharmacology. 2006 Jan;31(1):231-42.

47.
48.

Increases in hyperactive-impulsive symptoms predict relapse among smokers in nicotine replacement therapy.

Rukstalis M, Jepson C, Patterson F, Lerman C.

J Subst Abuse Treat. 2005 Jun;28(4):297-304.

PMID:
15925263
49.

Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women.

Colilla S, Lerman C, Shields PG, Jepson C, Rukstalis M, Berlin J, DeMichele A, Bunin G, Strom BL, Rebbeck TR.

Pharmacogenet Genomics. 2005 Jun;15(6):393-8.

50.

Ignorance of hedonic adaptation to hemodialysis: a study using ecological momentary assessment.

Riis J, Loewenstein G, Baron J, Jepson C, Fagerlin A, Ubel PA.

J Exp Psychol Gen. 2005 Feb;134(1):3-9. doi: 10.1037/0096-3445.134.1.3.

PMID:
15702959

Supplemental Content

Loading ...
Support Center